NCT05982522 2026-03-27
IN10018 Combination Therapy in Previously-treated Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Withdrawn
InxMed (Shanghai) Co., Ltd.
University of Texas Southwestern Medical Center
Partner Therapeutics, Inc.
Medical College of Wisconsin
Genfleet Therapeutics (Shanghai) Inc.
NantPharma, LLC
Samsung Medical Center
Samsung Medical Center
Celgene
PTS International Inc.
Dana-Farber Cancer Institute